PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 21497499-5 2012 In DU145 cells, piceatannol attenuated the secretion and messenger RNA levels of matrix metalloproteinase-9, urokinase-type plasminogen activator (uPA) and vascular endothelial growth factor (VEGF). 3,3',4,5'-tetrahydroxystilbene 16-27 vascular endothelial growth factor A Homo sapiens 156-190 21497499-5 2012 In DU145 cells, piceatannol attenuated the secretion and messenger RNA levels of matrix metalloproteinase-9, urokinase-type plasminogen activator (uPA) and vascular endothelial growth factor (VEGF). 3,3',4,5'-tetrahydroxystilbene 16-27 vascular endothelial growth factor A Homo sapiens 192-196 21497499-10 2012 Interleukin-6 treatment was also shown to enhance the secretion of uPA and VEGF, STAT3 phosphorylation and the migration of DU145 cells; these increases were suppressed by piceatannol. 3,3',4,5'-tetrahydroxystilbene 172-183 vascular endothelial growth factor A Homo sapiens 75-79 21642504-8 2011 ANG II-, EGF-, and VEGF-induced tube formation and aortic sprouting were attenuated by the Syk inhibitor piceatannol and by Syk short hairpin interfering (sh)RNA and small interfering RNA, respectively. 3,3',4,5'-tetrahydroxystilbene 105-116 vascular endothelial growth factor A Homo sapiens 19-23 21642504-9 2011 ANG II, EGF, and VEGF increased Syk phosphorylation, which was inhibited by piceatannol and Syk shRNA in EA cells and HUVECs. 3,3',4,5'-tetrahydroxystilbene 76-87 vascular endothelial growth factor A Homo sapiens 17-21 15665043-6 2005 The STAT3 inhibitor piceatannol decreased both OSM-induced VEGF release and synergy between OSM and IL-1beta, without affecting responses to IL-1beta alone. 3,3',4,5'-tetrahydroxystilbene 20-31 vascular endothelial growth factor A Homo sapiens 59-63 15665043-7 2005 Piceatannol also inhibited OSM-induced VEGF mRNA expression. 3,3',4,5'-tetrahydroxystilbene 0-11 vascular endothelial growth factor A Homo sapiens 39-43 32824997-0 2020 Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor. 3,3',4,5'-tetrahydroxystilbene 0-11 vascular endothelial growth factor A Homo sapiens 97-131 32824997-5 2020 In human umbilical vein endothelial cells (HUVECs), piceatannol markedly reduced the VEGF-induced cell proliferation, migration, invasion, as well as tube formation without affecting cell viability. 3,3',4,5'-tetrahydroxystilbene 52-63 vascular endothelial growth factor A Homo sapiens 85-89